|
Ceramide NanoLiposome (Ceraxa) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Ceramide NanoLiposome
Charlottesville, Virginia1 trial
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
University of Virginia Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.